Division of Respirology, Department of Medicine, McMaster University, Hamilton, Canada.
Firestone Institute for Respiratory Health, St Joseph's Healthcare, 50 Charlton E, Hamilton, ON, L8N 4A6, Canada.
Lung. 2024 Dec;202(6):767-774. doi: 10.1007/s00408-024-00744-9. Epub 2024 Sep 13.
Diabetes is a risk factor for the development of vascular disease, chronic kidney disease, retinopathy, and neuropathy. Diabetes is a co-morbid condition commonly present in patients with respiratory disorders but the extent to which it influences ventilatory capacity, gas exchange, and functional capacity is not well known. Research question Does the presence of diabetes contribute to impairment in spirometry, gas transfer, and exercise capacity?
Retrospective analysis of all subjects who performed incremental cardio-pulmonary exercise testing (CPET) between 1988 and 2012 at McMaster University Medical Centre. The impact of diabetes on physiological outcomes and maximum power output (MPO) was assessed using stepwise multiple additive linear regression models including age, height, weight, sex, muscle strength, and previous myocardial infarct as co-variates, and was also stratified based on BMI categories.
40,776 subjects were included in the analysis; 1938 (5%, 66% male) had diabetes. Diabetics were older (59 vs. 53 years), heavier (88.3 vs.78.0 kg), and had a higher BMI (31 vs. 27 kg/m). The presence of diabetes was independently associated with a reduction in FEV1 (- 130 ml), FVC (- 220 ml), DLCO (- 1.52 ml/min/mmHg), and VA (- 340ml) but not KCO. Patients with diabetes achieved a lower % predicted MPO[diabetic subjects 70% predicted (670 kpm/min ± 95% CI 284) vs. 80% in non-diabetics (786 kpm/min ± 342), p < 0.001]. With the exception of KCO, these differences persisted across BMI categories and after adjusting for MI.
The presence of diabetes is independently associated with weaker muscles, lower ventilatory and gas transfer capacity and translates to a lower exercise capacity. These differences are independent of age, height, weight, sex, and previous MI.
糖尿病是血管疾病、慢性肾病、视网膜病变和神经病变发展的一个风险因素。糖尿病是一种常见的合并症,常存在于患有呼吸障碍的患者中,但它对通气能力、气体交换和功能能力的影响程度尚不清楚。
糖尿病的存在是否会导致肺功能检查、气体转移和运动能力受损?
对 1988 年至 2012 年间在麦克马斯特大学医学中心进行递增心肺运动测试(CPET)的所有受试者进行回顾性分析。使用逐步多元线性回归模型评估糖尿病对生理结果和最大功率输出(MPO)的影响,模型中包括年龄、身高、体重、性别、肌肉力量和既往心肌梗死作为协变量,并根据 BMI 类别进行分层。
共纳入 40776 例受试者;其中 1938 例(5%,66%为男性)患有糖尿病。糖尿病患者年龄更大(59 岁比 53 岁),体重更重(88.3 千克比 78.0 千克),BMI 更高(31 千克/平方米比 27 千克/平方米)。糖尿病的存在与 FEV1(-130ml)、FVC(-220ml)、DLCO(-1.52ml/min/mmHg)和 VA(-340ml)的降低独立相关,但与 KCO 无关。患有糖尿病的患者达到的预测最大摄氧量百分比较低[糖尿病患者为 70%预测值(670kpm/min±95%CI284),而非糖尿病患者为 80%预测值(786kpm/min±342),p<0.001]。除了 KCO 之外,这些差异在 BMI 类别之间以及在调整了 MI 后仍然存在。
糖尿病的存在与肌肉力量减弱、通气和气体转移能力降低独立相关,进而导致运动能力下降。这些差异独立于年龄、身高、体重、性别和既往 MI。